((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto))
(Adds: Cintas, Paychex, Ryan Specialty, GFL Environmental, Getty Images, Guy Carpenter Updates: Julius Baer)
The following deals, mergers, acquisitions and divestitures were reported at 1430 GMT on Tuesday:
** Uniform rental company Cintas CTAS.O said it submitted a purchase offer for UniFirst UNF.N , valuing the uniform supplier at about $5.3 billion.
**The human resources management company Paychex
PAYX.O said it agreed to acquire payroll processing company Paycor PYCR.O for about $4.1 billion in cash.
** Ryan Specialty has agreed to acquire catamaran specialist AGM Velocity Risk Underwriters from private equity firm Oaktree Capital Management in a $525 million all-cash deal, the mutual giant of FM property acquiring Velocity Specialty Insurance Company (VSIC).
** GFL Environmental GFL.TO said it would sell its environmental services division in a deal valued at C$8 billion ($5.59 billion), as Canadian waste management company seeks to reduce debt and repurchase shares.
** Getty Images GETY.N said it would merge with Shutterstock rival SSTK.N to create a $3.7 billion stock image giant suited to the age of artificial intelligence, in the context of an operation which could be the subject of a competition examination.
** Julius Baer BAER.S said it agreed to sell its Brazilian wealth management business to Banco BTG Pactual
BPAC3.SA , a few days before Stefan Bollinger takes over as CEO after a difficult year for the Swiss bank.
**Guy Carpenter has completed the acquisition of the remaining 51.5% shares of Athens-based reinsurance broker Carpenter Turner.
** Dutch computer chip maker NXP said it had agreed to buy Austrian company TTTech Auto for $625 million, to strengthen its auto business.
** U.S. refiner Phillips 66 PSX.N said on Monday it would acquire EPIC Y-Grade GP and EPIC Y-Grade in an all-cash deal for $2.2 billion.
** Medical device maker Stryker SYK.N agreed Monday to acquire Inari Medical NARI.O , which makes devices to treat patients with venous diseases, in a cash deal worth of $4.9 billion.
